Plasma Protein Therapeutics Association (PPTA)
Home
About PPTA
Monography
Core SPC
Links
Newsletters
Search
Contact
Neurology/stroke
#
Article Title
1
Albumin attenuates DNA damage in primary-cultured neurons.
2
Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients.
3
Albumin therapy in acute stroke patients.
4
Oxidative and nitrosative stress in acute ischaemic stroke.
5
Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates.
6
Experimental treatments for acute ischaemic stroke.
7
Ischemia-Modified Albumin in Acute Stroke.
8
The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and prog
9
The ALIAS Pilot Trial. A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stro
10
The ALIAS Pilot Trial. A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stro
11
Serum albumin level and nosocomial pneumonia in stroke patients.
12
Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study.
13
Albumin protects cultured cerebellar granule neurons against zinc neurotoxicity.
14
Intraventricular albumin: an optional agent in experimental post-traumatic brain edema.
15
Albumin Treatment Reduces Neurological Deficit and Protects Blood-Brain Barrier Integrity After Acut
16
Effect of human albumin administration on clinical outcome and hospital cost in patients with subara
17
Serum Albumin Level as a Predictor of Ischemic Stroke Outcome.
18
Human Serum Albumin and its N-Terminal Tetrapeptide (DAHK) Block Oxidant-Induced Neuronal Death.
19
Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke.
20
Adventures in the Pathophysiology of Brain Ischemia: Penumbra, Gene Expression, Neuroprotection: The
21
Albumin use in neurosurgical critical care.
22
Bedside Monitoring of Circulating Blood Volume After Subarachnoid Hemorrhage.
23
Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant the
24
Transient forebrain ischemia increases the blood-brain barrier permeability for albumin in stroke-pr
25
Albumin promotes neuronal survival by increasing the synthesis and release of glutamate.
26
Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular resp
27
Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses an
28
Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin th
29
Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage.
Literature database
Alzheimer
ARDS/ALI
Ascites
Burns
Cardiac surgery
Hepatology
Hypo-albuminaemia
Hypo-volemia
Kidney/Liver transplant
Albumin Dialysis
Nephrotic Syndrome
Neurology/Stroke
Other indications
OHSS
Plasma exchange
Safety profile
Sepsis
Systematic Review
Malaria
Get your personal copy here >>